Biofrontera Inc. (NASDAQ:BFRI) Short Interest Update

Biofrontera Inc. (NASDAQ:BFRI) was the recipient of a large decline in short interest in January. As of January 15th, there was short interest totalling 292,400 shares, a decline of 44.9% from the December 31st total of 530,600 shares. Based on an average trading volume of 3,010,000 shares, the short-interest ratio is currently 0.1 days. Approximately 4.7% of the company’s stock are short sold.

Analysts Set New Price Targets

Separately, Benchmark reissued a “buy” rating and issued a $7.00 price objective on shares of Biofrontera in a report on Friday, November 15th.

Biofrontera Price Performance

Biofrontera stock traded up $0.01 during mid-day trading on Thursday, hitting $1.06. The company’s stock had a trading volume of 86,098 shares, compared to its average volume of 943,437. Biofrontera has a 52-week low of $0.61 and a 52-week high of $2.43. The firm’s 50 day moving average is $1.05 and its 200 day moving average is $1.06. The company has a market cap of $8.22 million, a PE ratio of -0.47 and a beta of 0.27.

Biofrontera Company Profile

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.